Advanced search
Publication Cover
Journal of Oral Microbiology Volume 15, 2023 - Issue 1
Submit an article Journal homepage
1,103
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Antimicrobial oral lavage reduces the SARS-CoV-2 load in intubated patients: randomized clinical trial

Letícia Mello Bezinellia Hospital Israelita Albert Einstein, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-8635-0508View further author information
ORCID Icon,
Luciana Corrêab School of Dentistry, University of São Paulo, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-5774-0750View further author information
ORCID Icon,
Stephany Beyerstedta Hospital Israelita Albert Einstein, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-3307-1644View further author information
ORCID Icon,
Érika Bevilaqua Rangela Hospital Israelita Albert Einstein, São Paulo, Brazil;c Nephorology Division, Federal University of Sao Paulo, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0003-0982-2484View further author information
ORCID Icon,
Carlos Benitezd Latin American Oral Health Association, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-8512-6176View further author information
ORCID Icon,
Nelson Hamerschlaka Hospital Israelita Albert Einstein, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-5140-5310View further author information
ORCID Icon,
João Renato Rebello Pinhoa Hospital Israelita Albert Einstein, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0003-3999-0489View further author information
ORCID Icon,
Debora Hellera Hospital Israelita Albert Einstein, São Paulo, Brazil;e Postgraduate Program in Dentistry, Universidade Cruzeiro do Sul, São Paulo, Brazil;f Department of Periodontology, School of Dentistry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5084-8179View further author information
ORCID Icon &
Fernanda de Paula Eduardoa Hospital Israelita Albert Einstein, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0001-6939-988XView further author information
ORCID Icon show all
Article: 2152179 | Received 13 Sep 2022, Accepted 22 Nov 2022, Published online: 13 Dec 2022

References

  • Illingworth CJ, Hamilton WL, Warne B, et al. Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections. eLife. 2021;10:e67308.
  • Lavorini F, Usmani OS, Dhand R. Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic. Intern Emerg Med. 2021;30:1–7.
  • Fernandes LL, Pacheco VB, Borges L, et al. Saliva in the diagnosis of COVID-19: a review and new research directions. J Dent Res. 2020;99(13):1435–1443.
  • Huang N, Pérez P, Kato T, et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021;27:892–903.
  • Zhu J, Guo J, Xu Y, et al. Viral dynamics of SARS-CoV-2 in saliva from infected patients. J Infect. 2020;81(3):e48–e50.
  • Nestor CC, Wang S, Irwin MG. Are tracheal intubation and extubation aerosol-generating procedures? Anaesthesia. 2021;76(2):151–155.
  • Nseir S, Martin-Loeches I, Povoa P, et al. Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort. Crit Care. 2021;25(1):177.
  • Zhao T, Wu X, Zhang Q, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev. 2020;12(12):CD008367.
  • Davies K, Buczkowski H, Welch SR, et al. Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes. J Gen Virol. 2021 Apr;102(4):001578.
  • Steinhauer K, Meister TL, Todt D, et al. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European standard EN 14476. J Hosp Infect. 2021;111:180–183.
  • Jain A, Grover V, Singh C, et al. Chlorhexidine: an effective anticovid mouth rinse. J Indian Soc Periodontol. 2021;25(1):86–88.
  • Meister TL, Brüggemann Y, Todt D, et al. Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2. 2020. J Infect Dis. 2020;222(8):1289–1292.
  • Huang YH, Huang JT, Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients. J Med Virol. 2021;93(7):4370–4373.
  • Damião Costa D, Brites C, Nunes Vaz S, et al. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: a randomized clinical trial. Oral Dis. 2021 Nov 26. DOI:10.1111/odi.14086.
  • Yoon JG, Yoon J, Song JY, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020;35(20):e195.
  • Eduardo FP, Corrêa L, Heller D, et al. Salivary SARS-CoV-2 load reduction with mouthwash use: a randomized pilot clinical trial. Heliyon. 2021 Jun;7(6):e07346.
  • Kampf G. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents. Infect Prev Pract. 2020;2(2). DOI:10.1016/j.infpip.2020.100044
  • Araujo DB, Machado RRG, Amgarten DE, et al. SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network. Mem Inst Oswaldo Cruz. 2020;23(115):e200342.
  • Aoki MN, de Oliveira Coelho B, Góes LGB, et al. Colorimetric RT-LAMP SARS-CoV-2 diagnostic sensitivity relies on color interpretation and viral load. Sci Rep. 2021;11(1):9026. 7.
  • Linley E, Denyer SP, McDonnell G, et al. Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action. J Antimicrob Chemother. 2012;67(7):1589–1596.
  • Cousido MC, Tomás Carmona I, García-Caballero L, et al. In vivo substantivity of 0.12% and 0.2% chlorhexidine mouthrinses on salivary bacteria. Clin Oral Investig. 2010;14(4):397–402.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.